Literature DB >> 12458825

An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol.

M J Doenhoff1, R G Stanley, K Griffiths, C L Jackson.   

Abstract

In affluent societies the prevalences of so-called 'Western' diseases such as atherosclerosis, allergies and autoimmune disorders appear to have increased, while many diseases caused by communicable infections are now relatively less common. To test whether there may be a causal relationship we examined the effects of Schistosoma mansoni infections in mice that develop cardiovascular pathology as a result of a genetic deficiency in apolipoprotein E (apoE-/-). The development of atherosclerotic lesions in the aortic arch and brachiocephalic artery of the apoE-/- mice was reduced by approximately 50% in mice with the parasitic infection, when comparison was made with uninfected control mice fed the same diet. Observations on S. mansoni-infected conventional laboratory mice indicate that patent schistosome infections could be counteracting the effects of an atherogenic diet by modulating host lipid metabolism and inducing a reduction in blood total cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458825     DOI: 10.1017/s0031182002002275

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  38 in total

1.  Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia.

Authors:  Sarinnapha Vasunilashorn; Eileen M Crimmins; Jung Ki Kim; Jeff Winking; Michael Gurven; Hillard Kaplan; Caleb E Finch
Journal:  Am J Hum Biol       Date:  2010 Nov-Dec       Impact factor: 1.937

2.  The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model.

Authors:  Tamar R Aprahamian; Xuemei Zhong; Shahzada Amir; Christoph J Binder; Lo-Ku Chiang; Lamyaa Al-Riyami; Raffi Gharakhanian; Margaret M Harnett; William Harnett; Ian R Rifkin
Journal:  Int J Parasitol       Date:  2015-02-07       Impact factor: 3.981

Review 3.  A worm of one's own: how helminths modulate host adipose tissue function and metabolism.

Authors:  Bruno Guigas; Ari B Molofsky
Journal:  Trends Parasitol       Date:  2015-05-16

Review 4.  Nematodes and human therapeutic trials for inflammatory disease.

Authors:  D E Elliott; J V Weinstock
Journal:  Parasite Immunol       Date:  2017-04-18       Impact factor: 2.280

5.  Schistosoma mansoni Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype.

Authors:  Diana Cortes-Selva; Andrew F Elvington; Andrew Ready; Bartek Rajwa; Edward J Pearce; Gwendalyn J Randolph; Keke C Fairfax
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561

Review 6.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

7.  The changing microbial environment and chronic inflammatory disorders.

Authors:  Graham Aw Rook
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

Review 8.  Helminth infection in populations undergoing epidemiological transition: a friend or foe?

Authors:  Aprilianto Eddy Wiria; Yenny Djuardi; Taniawati Supali; Erliyani Sartono; Maria Yazdanbakhsh
Journal:  Semin Immunopathol       Date:  2012-11-06       Impact factor: 9.623

Review 9.  Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis.

Authors:  Graham A W Rook
Journal:  Immunology       Date:  2009-01       Impact factor: 7.397

10.  Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individuals.

Authors:  Crina I A Balog; Oleg A Mayboroda; Manfred Wuhrer; Cornelis H Hokke; André M Deelder; Paul J Hensbergen
Journal:  Mol Cell Proteomics       Date:  2010-01-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.